All posts by medical

AAFP President: We Need to Go Forward, Not Backward, on Racial … – Patient Care Online

"As a family physician one finding that particularly stood out to me is that adults of color were more likely than white adults to report not having a usual doctor or provider and to have to go without care because of the cost."

American Academy of Family Physicians president Tochi Iroku-Malize, MD, MPH, MBA, referred to findings from the recent Kaiser Family Foundation update to its data on health and health care in the US by race and ethnicity. The update revealed that approximately one-third of Hispanic adults, one-quarter of American Indian Alaskan Native adults, and 1 in 5 Black and Asian adults do not have a personal health care provider vs 16% of White adults.

Among other grave concerns about the findings, Iroku-Malize framed data on US maternal and infant mortality among racial and ethnic minorities as moving backward in the 21st century, not forward. More of her conversation with Patient Care follows.

Tochi Iroku-Malize, MD, MPH, a family physician in Long Island, New York, is current president of the American Academy of Family Physicians. Iroku-Malize serves as founding chair and professor of family medicine for the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in Hempstead, New York, and is senior vice president and chair of the family medicine service line for Northwell Health. She oversees 4 family medicine residency programs and 3 fellowships spread across 23 hospitals. She was previously the director of the family medicine residency program at Southside Hospital in Bay Shore, New York. She is currently a member of the Society of Teachers of Family Medicine and is active in the Association of Departments of Family Medicine.

Read more here:

AAFP President: We Need to Go Forward, Not Backward, on Racial ... - Patient Care Online

Fact Or Fiction: 10 Common Beliefs About Sun Damage & Skin Health – Study Finds

Skin cancer is the most common cancer in the United States. According to the American Academy of Dermatology, the condition affects more than 3 million people annually. About 99 percent of the cases are caused by damage from the ultraviolet rays of the sun. Skin cancer is virtually 100 percent preventable, because you control your sun exposure.

One in five Americans will develop skin cancer by age 70. Non-melanoma skin cancer, however, is often excluded from cancer statistics, and is not reported in global statistics because it is so very common and under-diagnosed. It is also frequently managed within primary care (e.g., family medicine) without being reported, according to the World Cancer Research Fund International. Melanoma cases are rapidly rising across the U.S., however, and this very dangerous type of skin cancer on its own is expected to become the second most common cancer in the coming years.

Test your knowledge about sun damage and learn how to minimize your risk of developing skin cancer.Do you thinkthe commonbeliefs about sun damage and skin health listed below are fact or fiction?

Fiction: A study conducted by the United States Food and Drug Administration (FDA) determined thatless than 25 percent of sun damage occurs before the age of 18. After that, 10 percent more accrues for every decade of life. However, one blistering sunburn before the age of 18 can double your chance of developing melanoma. The 80 percent figure was based on incorrect information and miscalculations.

Intervention at any age is beneficial for starting protection and repairing some damage. A broad-spectrum sunscreen (covers both UVA and UVB rays) with a sun protection factor (SPF) of 30 should be used daily on your face and any other exposed areas of skin. Limit getting direct sun exposure, and use barrier antioxidant products (e.g., zinc oxide.) Heres a list of the best sunscreens, according to experts.

Fact: You can burn in the shade, from UV radiation reflected off nearby surfaces. According to the World Health Organization (WHO), surfaces youd never suspect of reflecting UV rays canincrease your risk of burning. Sea foam reflects 25 percent of UV radiation and sand reflects 15 percent. Grass, soil, and water reflect less than 10 percent. Fresh snow doubles your UV exposure. Take care when outdoors to protect yourself from burning.And by the way, its important to use sunscreen for your pets too.

Fiction: The bronzing of the skin with tanning is the result of DNA damage. UV light damages skin cell DNA and the body tries to repair the damage. The process produces melanin, which darkens the skin.

Fiction: You can get a more serious sunburn on cloudy days than in direct sunlight. According to the World Health Organization, 80 percent of the suns ultraviolet rays pass through a light cloud cover. Theres also an interesting phenomenon called the broken-cloud effect.

Partly cloudy days can intensify surface UV radiation by 25 percent and make the UV rays associated with skin damage 40 percent greater. Scientists speculate that the effect may occur when UV rays are reflected off the sides of dense clouds or are redirected when passing through thin clouds.

Fiction: Naturally dark skin can burn and suffer the damage that is associated with developing skin cancer. A study conducted by the American Academy of Dermatology revealed that African Americans are the most likely to die from melanoma, because they are least likely to be diagnosed early in the course of the disease. There is some protection associated with a naturally elevated level of melanin, but some sun damage is still occurring.

Dr. Erin Boh, chair and professor of dermatology at Tulane University School of Medicine, tells The Healthy: Remember that children can get sunburned despite their skin color. I advise all patients to use at least an SPF 30 sunscreen or a physical barrier such as zinc or titanium oxide.

Fact: You can have a sunburn long before your skin becomes visibly pink, says Dr. Michele Green, a dermatologist at Lenox Hill Hospital in New York City. In fact, the first sign you may be getting a sunburn is that your skin will start to itch and feel hot, in an interview with The Healthy. Other signs include thirst, skin tightness, and pain with touch. The skin may turn white when you apply pressure to it.

Fact: According to the American Academy of Dermatology, a single session in a tanning bed can increase your risk of melanoma by 20 percent, squamous cell carcinoma by 67 percent, and basal cell carcinoma by 29 percent. Women younger than 30 are six times more likely to develop melanoma by using tanning beds.Some states prohibit their use by children.Heres a list of thebest self-tanning lotions for individuals who want to avoid the harms from using tanning beds.

Fact: Strawberriescontain vitamin C and tannins, which are beneficial for sun protection, and tomatoes contain lycopene, which is known to protect the skin from UV damage, Dr. Green adds. But while eating them may offer some natural sun protection, it shouldnt be a reason to skip the sunscreen.

Bonus knowledge: Prior research also shows that eating grapes can protect you from sunburn. Adding them to your fruit salad alongside strawberries and tomatoes can give you a nice edible sunscreen, scientists say.

Fiction: Clothing yields an SPF of 4 to 8, with darker colors and tighter weaves of fabric being more protective, according to the Skin Cancer Foundation.

What aboutso-called sun-protective clothing?UPF (ultraviolet protection factor) clothing and hats provide more protection and block more UV radiation than do untreated clothes. The protection decreases with repeated washes. Rit Sun Guardis a powdered product which can be washed into clothing to provide UV protection. It increases the UPF of the clothing to 30 and lasts for up to 20 washes.

Fact: You cant make a sunburn heal faster, but you can get some relief from the symptoms.

If you catch a sunburn earlyas soon as you feel the tingleyou can slow it down and reduce the severity with a non-steroidal anti-inflammatory drug like Aleve or Advil, says Dr.Christopher Huerter, associate professor of medicine and chief of dermatology at Creighton University School of Medicine in Omaha, in an interview with The Healthy. Cold compresses and aloe can also be helpful. You should see a doctor if you get a fever and chills. In that case, says Dr. Huerter, we would give [patients] a dose of oral corticosteroid, like prednisone.

As always, if you are concerned about your skin health, dont hesitate to reach out to your doctor with your questions.

More:

Fact Or Fiction: 10 Common Beliefs About Sun Damage & Skin Health - Study Finds

Valor Health discontinuing labor and delivery – Idaho News

EMMETT, Idaho

Valor Health joins a growing number of hospitals in Idaho that will cease to provide Labor and Delivery services.

Valor health released a statement announcing a major transition in its obstetrics program, shifting resources away from inpatient labor and delivery to enhanced outpatient prenatal and postnatal care within the hospitals family medicine clinic.

The decision comes after a historically low delivery rate predicted for this year, fewer than 50 babies, and an ongoing shortage of qualified staff to work in the demanding field.

Brad Turpen, CEO of Valor Health, says the decision to stop providing labor and delivery services will take effect June 1, 2023. Turpen recommended Valor Health stop providing labor and delivery services and the Board of Trustees voted to support the recommendation. Valor Health is beginning efforts to transition existing patients in the lead up to June 1.

See the original post:

Valor Health discontinuing labor and delivery - Idaho News

Black pregnant people are twice as likely to die in childbirth. How … – MPR News

CATHY WURZER: The first part of the show is kind of focused on health and well-being. New data from the CDC out this month shows that the rate of folks dying in pregnancy or childbirth has risen considerably in recent years. There was a 40% increase in maternal deaths between 2020 and 2021, and that rate was more than twice as high for Black women whose maternal mortality rate was 70 deaths for every 100,000 live births.

What gives with that? We have Dr. Jay-Sheree Allen on the line from the Mayo Clinic. She's going to talk about why pregnancy and birth is still so very unsafe for some women in the US. Dr. Jay, welcome back.

JAY-SHEREE ALLEN: Thank you so much for having me again, Cathy. It's great to be here.

CATHY WURZER: Well, this is serious, serious stuff here. I mean, you look at the figures from the CDC. Maternal death is 10 times likelier in the US than it is in countries like Australia. You wouldn't think that to be true, but it is. What's going on?

JAY-SHEREE ALLEN: This is a tough one. This is a really hard one. Many of the things I talk to you about-- I'm the physician telling you kind of that perspective. But having had complications after my pregnancy, I felt like this article hit a little close to home for me. It's multifactorial, Cathy.

It's not any one answer, right? So we have to think of things like increased rates of chronic illness in our OB population, so rates of obesity, diabetes, heart disease in women who are giving birth-- in our country, prenatal care and inadequate prenatal care. I think it was the March of Dimes put out some statistics that said there are 6.9 million women in this country of childbearing age with no access or little access to care.

That all matters. Cost-related issues when it comes to care-- and we have to think too about missed or even delayed opportunities for treatment. We've heard the stories from Beyonce and from Serena Williams. I mean, some of the most well resourced women in this country still experiencing complications. And of course, I'd be remiss, right, if we don't bring up some of the structural biases and racism that are kind of ingrained in our system.

CATHY WURZER: I'm wondering about the role that COVID may have played in this, too. Can we attribute some of this spike to the pandemic?

JAY-SHEREE ALLEN: Yes. So these more recent numbers-- so we've been on the rise for the past few years, but there's certainly been a larger increase. I think up to 25% of those new numbers reported in 2021 are being attributed to COVID. And it's not entirely clear why, but some of the things-- blood clots with this virus, rates of pre-eclampsia.

Even I've seen mentions of people delaying or forgoing visits or going to appointments when the virus was at its height, and we really didn't understand what was taking place.

CATHY WURZER: I'm wondering-- you lay out a really dire situation here. What are doctors doing to try to help pregnant women?

JAY-SHEREE ALLEN: We in the medical community are aware that this is a major problem, and we've certainly been working on this on the back end. I think, though, it's multilayered. So with any institution, you see that there is training happening at this point, whether it's upstander training or there's more attention being placed on biases that we once had-- some women being able to tolerate pain than others, trusting or not believing.

I think the doctors are working on that. We do participate in continuing medical education courses to ensure that our knowledge base is at its height when we are caring for our vulnerable patients. But I think this goes beyond what an individual doctor or even just the health system is able to do. I think we need to take that 40,000 foot view and look a little bigger, right?

What are the policies like in this country that support or don't support the health and the well-being of women who are pregnant? Just getting granular for a second, Cathy. Think of just how common-- even the healthiest pregnancy with zero complications, you still have a certain number of appointments that you need to attend to see your midwife or to see your physician who's caring for you.

What are our jobs like in terms of giving us time off for these very much expected appointments, right? What sort of schedule templates are built in to allow us to not have to use PTO, which most women are trying to save so they can spend more time with the child after they are born considering our laws in the postpartum period? So it's really complex and beyond just the doctor.

CATHY WURZER: Wow. So I wonder, getting back toward the beginning part of our conversation about the public health aspects of this, do we also, do you think, need to have more education for women to be healthier going into a pregnancy? You mentioned diabetes, obesity, heart disease-- work on those public health issues as well?

JAY-SHEREE ALLEN: I think yes. I think yes, but I am not one of the "fix the woman" sort of-- I think we need to take that bigger, that larger view so we're addressing all of the different areas we can and not just victim blaming. But I think there's definitely room for improving our lifestyles or healthier lifestyles as much as we possibly can.

And again, recognizing that this is within the confines of the society in which we live, right? I heard someone say that the social determinants of health is the fishbowl we all swim in. It's the water we're all in, right? So you can be motivated to change some of those things, but your environment has a lot to do with this.

And then another important thing to recognize in this data that came out from the CDC-- the rates of maternal mortality also increased with age. And so older women, women over the age of 40 in particular, had higher rates than younger women under the age of 25. So I think that's also worth mentioning.

CATHY WURZER: Does that come as a surprise to you?

JAY-SHEREE ALLEN: No, it doesn't. It doesn't. And even now, a lot of us-- and I say us, myself included-- are delaying childbirth for many different reasons, in pursuit of our professional goals or working around our careers, and again, trying to fit within the standards in the confines of the society that we live in.

CATHY WURZER: There's a lot to unpack here. Always a pleasure talking to you, though, Doctor. I appreciate this. Thank you so much.

JAY-SHEREE ALLEN: You're so welcome. Thanks for having me.

CATHY WURZER: Dr. Jay-Sheree Allen. She's a family medicine physician at Mayo Clinic, also the host of the podcast Millennial Health. Get it wherever you ever get your pods.

Visit link:

Black pregnant people are twice as likely to die in childbirth. How ... - MPR News

ProJenX Announces Formation of Scientific Advisory Board – Yahoo Finance

NEW YORK, March 30, 2023 /PRNewswire/ -- ProJenX, Inc., a clinical-stage biotechnology company developing novel, brain-penetrant therapies targeting biologically-defined pathways for the treatment of amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases, today announced the formation of its Scientific Advisory Board (SAB). The SAB, which includes internationally renowned experts in stem cell biology, ALS disease modeling and drug discovery, and clinical development across neurodegeneration, will provide strategic guidance for the development of ProJenX's lead candidate prosetina brain-penetrant, orally available, MAP4K inhibitorand additional pipeline expansion activities.

ProJenX (PRNewsfoto/ProJenX)

The inaugural members are Leonard van den Berg, MD, PhD (UMC Utrecht), Claire Henchcliffe, MD, DPhil (UC Irvine), Joe Lewcock, PhD (Denali Therapeutics), Lee Rubin, PhD (Harvard University), and Neil Shneider, MD, PhD (Columbia University).

Dr. Rubin, Professor of Stem Cell and Regenerative Biology at Harvard University and Co-Director of the Neuroscience Program at the Harvard Stem Cell Institute, said, "My own laboratory's longstanding interest in patient-derived models of ALS and in the identification of neuroprotective compounds pointed us, much like ProJenX, to MAP4Ks as key regulators of motor neuron degeneration. I am excited by the research behind prosetin and look forward to working with ProJenX to elucidate and intervene in the key cellular pathways involved in ALS and neurodegeneration."

"To meaningfully alter the course of disease in ALS, we must advance better-validated therapeutic candidates," said Dr. Shneider, Director of the Eleanor and Lou Gehrig ALS Center and Claire Tow Associate Professor of Neurology at Columbia University Irving Medical Center. "The long-term collaboration between Columbia University researchers and Project ALS that led to prosetin is an example of the rational, scientifically rigorous approach required for clinical success, and I am eager to work with the ProJenX team to move prosetin forward in ALS."

Story continues

Erin Fleming, Co-Founder and Vice President of Research & Development at ProJenX, said, "We are honored to convene a world-class Scientific Advisory Board, who represent peerless experience and knowledge across ALS drug development, data-driven clinical trial design, and the MAP kinase pathway in neurodegeneration. With our advisors' leadership, ProJenX is poised to translate decades of scientific discovery to people with ALSbeginning with prosetin."

ProJenX's SAB member biographies can be viewed here.

About ProJenXProJenX is a clinical-stage biotechnology company developing novel, brain-penetrant, targeted therapies to address neurodegenerative diseases, with an initial focus on ALS. ProJenX was created out of a long-term research collaboration between Project ALS and researchers atColumbia Universityto rapidly develop and commercialize its lead therapy candidate, prosetin, for people living with ALS. At the heart of ProJenX's approach is an innovative, patient-specific, cell-based drug discovery platform that can be leveraged for research and drug development for ALS and other debilitating brain diseases. For more information, visitprojenx.com.

About ProsetinProsetin is a potent, oral, brain-penetrant, mitogen-activated protein kinase (MAP4K) inhibitor targeting endoplasmic reticulum (ER) stress. ER stress is a common feature across sporadic and familial forms of ALS, and MAP4Ks emerged as the critical regulators of ER stress-mediated motor neuron loss in a patient-specific, cell-based discovery platform developed by researchers atColumbia University. ProJenX is currently conducting a three-part Phase 1 clinical trial, PRO-101, investigating prosetin in healthy individuals and people living with ALS. Prosetin is an investigational new drug and has not been approved by the FDA.

Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/projenx-announces-formation-of-scientific-advisory-board-301785361.html

SOURCE ProJenX

Here is the original post:
ProJenX Announces Formation of Scientific Advisory Board - Yahoo Finance

Pathogen mapped: Evolution and potential treatments – Science Daily

A parasite which has devastating impacts on agriculture and human health is the first pathogen to have its proteins located and mapped within its cells -- providing clues to their function and helping to identify potential drug targets.

African trypanosomes are parasites transmitted by tsetse flies that cause sleeping sickness in humans (presenting as fever, anaemia and, in serious cases, death) and a similar disease celled nagana in cattle. These parasites have made large areas of Africa unsuitable for livestock production, costing rural farmers up to ~3.7 billion pounds each year in lost revenue.

For the first time ever, scientists have developed a detailed "protein atlas" of a pathogen -- a kind of biological map that locates proteins in cells. They conducted the research on Trypanosoma brucei (T. brucei), helping to understand where proteins are within its cells, providing functional insights that may ultimately help treat parasite infections.

The benefits of this ground-breaking research by the Universities of Warwick, Oxford and Oxford Brookes do not stop there. In mapping the proteins within T. brucei, scientists now understand more about its evolutionary cell biology. Like humans, T. brucei are eukaryotes -- meaning their cells have a nucleus. However, T. brucei evolved in a very divergent way to human cells. Exploring protein mapping sheds light on how it evolved to be so different.

Samuel Dean, Assistant Professor of parasitology at the University of Warwick, said: "In this study, we genetically modified trypanosome parasites to make proteins attached to a green fluorescent dye. This helped to show exactly where its proteins are within the cell. Using this information, we are able to understand more about what these proteins might be doing. Up until now 50% of the proteins in T. brucei had unknown functions.

"This has significant impacts on our understanding of pathogen evolution and provides functional clues for thousands of otherwise uncharacterised proteins. This will help further investigations and may help to inform on new treatments for these terrible diseases."

Professor Keith Matthews, expert in parasite biology at the University of Edinburgh, added: "This important resource will be of immense long-term value to researchers focused on these devastating pathogens, but also helps to understand the protein function and evolution of all nucleated cells, including our own."

University of Ghana senior lecturer, Theresa Manful Gwira, who is Head of Research Training at the West African Centre for Cell Biology of Infectious Pathogens, added: "This is a very important work, and a powerful resource that will be useful to many researchers including African scientists that work on the devastating African trypanosomiasis, thus contributing to a better understanding of the parasite biology."

This research was funded by The Wellcome Trust.

See the original post here:
Pathogen mapped: Evolution and potential treatments - Science Daily

Artificial Cells The Powerhouse of the Future – SciTechDaily

Concept of artificial chloroplasts and mitochondria within a liposome for self-sustaining energy generation through photosynthesis and cellular respiration. Credit: Biological Interface Group, Sogang University

Assessing how energy-generating synthetic organelles could sustain artificial cells.

Researchers have assessed the progress and challenges in creating artificial mitochondria and chloroplasts for energy production in synthetic cells. These artificial organelles could potentially enable the development of new organisms or biomaterials. The researchers identified proteins as the most crucial components for molecular rotary machinery, proton transport, and ATP production, which serves as the cells primary energy currency.

Energy production in nature is the responsibility of chloroplasts and mitochondria and is crucial for fabricating sustainable, synthetic cells in the lab. Mitochondria are not only the powerhouses of the cell, as the middle school biology adage goes, but also one of the most complex intracellular components to replicate artificially.

In Biophysics Reviews, by AIP Publishing, researchers from Sogang University in South Korea and the Harbin Institute of Technology in China identified the most promising advancements and greatest challenges of artificial mitochondria and chloroplasts.

This could be an important milestone in understanding the origin of life and the origin of cells. Kwanwoo Shin

If scientists can create artificial mitochondria and chloroplasts, we could potentially develop synthetic cells that can generate energy and synthesize molecules autonomously. This would pave the way for the creation of entirely new organisms or biomaterials, author Kwanwoo Shin said.

In plants, chloroplasts use sunlight to convert water and carbon dioxide into glucose. Mitochondria, found in plants and animals alike, produce energy by breaking down glucose.

Once a cell produces energy, it often uses a molecule called adenosine triphosphate (ATP) to store and transfer that energy. When the cell breaks down the ATP, it releases energy that powers the cells functions.

In other words, ATP acts as the main energy currency of the cell, and it is vital for the cell to perform most of the cellular functions, said Shin.

The team describes the components required to construct synthetic mitochondria and chloroplasts and identifies proteins as the most important aspects for molecular rotary machinery, proton transport, and ATP production.

Previous studies have replicated components that make up the energy-producing organelles. Some of the most promising work investigates the intermediate operations involved in the complex energy-generating process. By connecting the sequence of proteins and enzymes, researchers have improved energy efficiency.

One of the most significant challenges remaining in trying to reconstruct the energy production organelles is enabling self-adaptation in changing environments to maintain a stable supply of ATP. Future studies must investigate how to improve upon this limiting feature before synthetic cells are self-sustainable.

The authors believe it is important to create artificial cells with biologically realistic energy-generation methods that mimic natural processes. Replicating the entire cell could lead to future biomaterials and lend insight into the past.

This could be an important milestone in understanding the origin of life and the origin of cells, Shin said.

Reference: Artificial organelles for sustainable chemical energy conversion and production in artificial cells: Artificial mitochondrion and chloroplasts by Hyun Park, Weichen Wang, Seo Hyeon Min, Yongshuo Ren, Kwanwoo Shin and Xiaojun Han, 28 March 2023, Biophysics.DOI: 10.1063/5.0131071

Read the original post:
Artificial Cells The Powerhouse of the Future - SciTechDaily

How cell mechanics influences everything | MIT News … – MIT News

High in the treetops of a Chinese rainforest, Ming Guo began to explore the influence of a single cell.

A student in Chinas Tsinghua University, Guo was studying the mechanical properties of plant cells. As part of his masters thesis he took on an intriguing question: Does a cells physical integrity its size, shape, squishiness, or stiffness have anything to do with how tall a tree grows?

In search of an answer, Guo visited forests across the Yunnan province, collecting leaves from the tallest trees, some towering over 200 feet too high for Guo himself to climb. So, he enlisted the help of a student in the universitys rock climbing club, who scaled the trees and retrieved leaves at various heights along their length.

After analyzing the individual plant cells within each leaf, Guo observed a pattern: The higher the leaves, the smaller the cells. And, more interesting still, the size of a single cell could more or less predict how tall a tree can grow.

This early work in tree cells made one thing clear in Guos mind: A cells physical form can play a role in the development of an entire organism. This realization motivated him to study cell mechanics, in plant and eventually animal cells, to see what more a cells physical properties can reveal about how cells, tissues, organs, and whole organisms grow.

People study cells in the context of their biology and biochemistry, but cells are also simply physical objects you can touch and feel, Guo says. Just like when we construct a house, we use different materials to have different properties. A similar rule must apply to cells when forming tissues and organs. But really, not much is known about this process.

His work in cell mechanics led him to MIT, where he recently received tenure and is the Class of 54 Career Development Associate Professor in the Department of Mechanical Engineering.

At MIT, Guo and his students are developing tools to carefully poke and prod cells, and observe how their physical form influences the growth of a tissue, organism, or disease such as cancer. His research bridges multiple fields, including cell biology, physics, and mechanical engineering, and he is working to apply the insights from cell mechanics to engineer materials for biomedical applications, such as therapies to halt the growth and spread of diseased and cancerous cells.

MIT is a perfect place for that in the long run, Guo says. Its cross-disciplinary and always very inspiring, and by interacting with different people outside of the field, you get more ideas. Its more likely that you can dig up something useful.

The nature of physical objects

Guo grew up in Shijiazhuang, a city that is a two-hour train ride from Beijing. Both his parents were engineers his father worked at the local factory, and his mother built teaching models of traffic systems at a vocational school. His parents worked hard, and like most factory families, they did not have the luxury of looking after their child when school was out.

In the summers, they had to go to work, and they would just lock me at home. Id throw my keys outside to someone to unlock the door so I could go play with them, Guo recalls.

He and his friends would head to a cluster of residential buildings near the factory, and spent their days climbing.

I liked to climb short buildings and towers and look at how they were structured, Guo recalls. There was also a small river where we tried to catch fish. Most families didnt have much savings at the end of the year and didnt spend much effort on education. But I remember as a kid having a lot of fun.

School, and science, came more into focus in high school, when Guo had the chance to visit a cousin who was attending Tsinghua University. He remembers being particularly drawn to a textbook on his cousins shelf, on the structural mechanics of bridges. The short stay inspired him to apply to the university one of the top two schools in the country. Once accepted, he headed to Tsinghua for a degree in mechanics.

After a brief foray into the mechanics of fluids, and a project involving simulations of an artificial blood pump, Guo decided to pivot, and focus instead on the mechanics of cells, plant cells in particular. Inspired by his advisor, he took up the topic of how a plant cells mechanical integrity influences how tall a tree can grow. The project grew into a masters thesis as Guo stayed on at Tsinghua as a masters student.

As I worked on plants, I realized that animal cells were also very interesting, Guo says. The nature of different materials, especially biological materials, and how to understand them simply as physical objects, was fascinating to me.

A profound impact

As he wrapped up his work with tree cells, Guo read up on animal cell research, gravitating to work by David Weitz, a Harvard University physicist who specializes in soft matter, including the mechanical properties of living cells. Weitzs work motivated Guo to apply to Harvards graduate program in applied physics.

In 2007, he arrived on the Cambridge campus the first time hed ever ventured outside China and felt lost amid a new and foreign landscape.

I had filled half my suitcase with ramen, and the first week I just ate ramen because I didnt know where to eat, Guo recalls. I also couldnt understand anything in some of my classes, because the type of English I learned in China was not the way people actually talk here.

After time, Guo found his footing and dove into work in Weitzs lab, where he focused his PhD thesis on understanding the nonequilibrium behavior, or the physical motions in a single cell, and investigating where the energy to generate such motions originates.

That work really shifted my direction, Guo says. I knew what I wanted to do: keep understanding how cell mechanics in multicellular systems like organs and tissues influence everything.

In 2015, he made the move to MIT, where he accepted a junior faculty position in the Department of Mechanical Engineering. At the Institute, he has shaped his research goals around developing new tools and techniques to better study living cells and how their physical and mechanical properties influence how cells move, respond, deform, and function.

In the last few years, weve made some big insights on how, if you change a cells mechanical environment, such as their stiffness or their water content, that has a major impact on some fundamental biochemistry, such as transcription and cell signaling, which in turn regulates multicellular growth, Guo says. So, cell mechanics can have a really profound impact on biology.

In addition to his research, Guo also enjoys teaching MIT students, most recently in 2.788 (Mechanical Engineering and Design of Living Systems), a class that challenges students to apply the mechanics of cells to design novel systems and machines. In a recent class, students have been using cardiac muscle cells to pump liquid through a microfluidic chip. A previous class amplified the natural voltage inside a plant to power a small wheel.

The most energetic and happy moments I have are in talking to students, Guo says. They often give me surprises or new ideas that I love and most look forward to.

In recent years, Guos research and teaching have expanded to consider not just the mechanics of single cells, but also multicellular systems a shift he credits with the arrival of his daughter.

She was born in 2016, and at that time, my entire group was working on single cells, Guo says. But seeing how shes developed, I feel that understanding something that complex is much more interesting. So, we have also started working on exploring the mechanics and mechanobiology of more complex systems such as tissues and embryos.

Read more:
How cell mechanics influences everything | MIT News ... - MIT News

Science journalist Rebecca Skloot to speak on ‘The Immortal Life of … – Virginia Tech Daily

She was born Loretta Pleasant. For most of her life, she was known as Henrietta Lacks. Since the 1950s, generations of cell biologists have known her mostly without being aware of it as HeLa, the nickname for the line of cells that inaugurated a new era in medical research.

The medical odyssey that made Lacks cells a cornerstone of modern medicine, chronicled in Rebecca Skloots 2010 bestseller "The Immortal Life of Henrietta Lacks," is a stunning object lesson in informed consent and bioethics and a sobering chapter in the long, shameful history of racial inequity and exploitation in medicine.

On April 11, Skloot, along with Shirley Lacks and Jeri Lacks Whye, will tell Lacks story and explore the troubling historical and ethical questions woven through it in a lecture on Virginia Techs Blacksburg campus.

The talk, part of the Hugh and Ethel Kelly Lecture Series, will take place at 2 p.m. in the Haymarket Theatre at Squires Student Center. Hosted by the Institute for Critical Technology and Applied Science in partnership with the College of Engineering, the event is free and open to the public but registration is requested.

The series of events that put Lacks at the center of a revolution in medical research began in 1951, when the Black mother of five sought treatment at Johns Hopkins Hospital for what turned out to be an aggressive cervical cancer. During the course of her treatment, doctors collected cells from her tumor and passed them along to a Johns Hopkins researcher wrestling with the challenge then consuming the medical community: growing human cells outside the human body.

Lab-grown cells would allow researchers to perform experiments and test treatments without endangering human patients. But until the cells from Lacks tumor showed up, no sample had ever survived for longer than a few days.

Lacks cells were different. They doubled their population every 24 hours in an apparently inexhaustible supply of identical copies. Lacks died in August 1951, but her cells which she didnt know were being cultured and hadnt given researchers consent to use divided over and over again in the laboratory, becoming the first immortalized human cell line.

This unlimited supply of cells transformed medical research. The vaccine for polio was developed through experiments conducted on HeLa cells. Researchers have relied on them to study diseases, including measles mumps, HIV, and ebola, and to develop treatments for cancers and viruses. HeLa cells were the first to be cloned and the first to be sent to space. They provided the backdrop for fundamental discoveries in genetics and other aspects of cell biology.

All of this was done without consulting, or even informing, Lacks' family, who only became aware that the cell line existed in the 1970s when they began receiving requests from researchers for blood samples. As part of the massive scientific and profit-making enterprise that was by then operating around HeLa cells, members of the family were used in research again, without their consent and their medical records shared.

It wasnt until Skloot began the reporting that ultimately became "The Immortal Life of Henrietta Lacks" that the Lacks family became aware of the magnitude of Henriettas transformative contributions to medicine and the lucrative biotech enterprise that fueled this research bonanza. Lacks' biological material had allowed companies to rake in massive profits selling HeLa cells by the trillions, but her descendants who shared the same biological material hadn't received any of that windfall.

Skloot used some of the books proceeds to establish The Henrietta Lacks Foundation, which has helped support some of the familys expenses. Some biotech companies have since contributed to this fund. But the ongoing debate over the responsible approach to Lacks legacy highlights the necessity of continuing to wrestle with these issues.

Sloots work, which covers topics from food politics to the intersection of race and medicine, has been featured in The New York Times and on National Public Radio, CBS Sunday Morning, the podcast "Radiolab," and numerous other outlets.

She has been recognized with awards from organizations including the National Academies of Science, the American Association for the Advancement of Science, and the Wellcome Trust.

She holds a bachelors degree in biological science and a masters degree in creative nonfiction.

The Hugh and Ethel Kelly Lecture Series is made possible by a fund from the estate of Ethel Kelly, who generously supported Virginia Tech and the College of Engineering in honor of her husband, Hugh. Hugh Kelly earned bachelors and masters degrees from the university and went on to play key roles in multiple groundbreaking projects over a long career at Bell Laboratories.

To honor Hugh Kellys technical accomplishments and the couples support of Virginia Tech, the College of Engineering and the Institute for Critical Technology and Applied Science established the lecture series and renamed the institute's headquarters building Kelly Hall in 2013. The Kellys generosity has allowed the institute to bring Nobel laureates, Pulitzer Prize winners, and other visionary leaders and thinkers to Blacksburg to share their work with the Virginia Tech community.

Visit link:
Science journalist Rebecca Skloot to speak on 'The Immortal Life of ... - Virginia Tech Daily

Mendus presents an update on the use of its DCOne platform to source high-quality NK cell therapies at the 8th Annual Innate Killer Summit – Yahoo…

Mendus AB

DCONE-DRIVEN EXPANSION OF MEMORY NK CELLS BUILDS THE BASIS FOR NOVEL PROPRIETARY PIPELINE PROGRAM

Mendus AB (Mendus publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies addressing tumor recurrence, today announced that it will present additional data highlighting the use of the companys proprietary DCOne platform for the ex vivo expansion of NK cells today at the 8th Annual Innate Killer Cell Summit in La Jolla, San Diego, CA.

Natural Killer (NK) cells are part of the innate immune system and form a first line of defense against infections and tumor cells. Memory NK cells are associated with improved tumor cell killing and significantly reduced relapse rates in bone marrow-transplanted leukemia patients. Memory NK cells therefore hold great therapeutic promise in the treatment of hematological cancers and potentially other tumor types.

Significant efforts in the NK field have been made to develop superior and reliable expansion methods for NK cells with optimal therapeutic efficacy, including efforts to improve memory phenotype. The NK cell research at Mendus has focused on using our proprietary DCOne platform to improve NK cell quality and specifically on memory NK cells, said Erik Manting, PhD, Chief Executive Officer of Mendus. The DCOne platform provides for an off-the-shelf source of cells which combine cancer cell and dendritic cell biology. Another important aspect of the DCOne cell line is that it is supported by an extensive regulatory dossier and has demonstrated an excellent safety profile in multiple clinical trials.

The data presented today and at SITC 2022 demonstrate that DCOne cells drive strong expansion of memory NK cells, which subsequently can be used in different therapeutic applications. The presence of activating ligands on the cell surface of DCOne-derived mature dendritic cells provide a mechanistic rationale for the observed expansion of memory NK cells with well-characterized molecular signatures.

Story continues

The Innate Killer Summit is an industry conference focused on improving patient care by advancing the understanding and enhancing of innate immune cell therapies. On March 30, 3.15pm PST (00:15 CET) Mendus CEO Erik Manting, PhD, will hold a presentation titled Developing Expansion Protocols to Enrich for Memory Phenotypes to Produce Quality over Quantity in Final NK Cell Therapy Products as part of the Clinical Scale Manufacturing track.

During the conference, Dr Manting also chaired a panel discussion titled Sharing a Vision of the Future for Commercial Scale Manufacturing of Innate Immune Cells on March 29.

FOR MORE INFORMATION, PLEASE CONTACT:

Erik MantingChief Executive OfficerE-mail: ir@mendus.com

INVESTOR RELATIONSCorey DavisLifeSci Advisors, LLCTelephone: + 1 212-915-2577E-mail: cdavis@lifesciadvisors.com

MEDIA RELATIONS

Mario BrkuljValency CommunicationsTelephone: +49 160 9352 9951E-mail: mbrkulj@valencycomms.eu

ABOUT MENDUS AB (PUBL)

Mendus is dedicated to changing the course of cancer treatment by addressing tumor recurrence and improving survival outcomes for cancer patients, while preserving quality of life. We are leveraging our unparalleled expertise in allogeneic dendritic cell biology to develop an advanced clinical pipeline of novel, off-the-shelf, cell-based immunotherapies which combine clinical efficacy with a benign safety profile. Based in Sweden and The Netherlands, Mendus is publicly traded on the Nasdaq Stockholm under the ticker IMMU.ST. http://www.mendus.com/

Attachment

Link:
Mendus presents an update on the use of its DCOne platform to source high-quality NK cell therapies at the 8th Annual Innate Killer Summit - Yahoo...